William Blair & Company
YTEN

William Blair & Company’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

William Blair & Company’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1
Closed -$26K – 2249
2015
Q1 		$26K Hold
1
– – ﹤0.01% 2107
2014
Q4 		$17K Hold
1
– – ﹤0.01% 2088
2014
Q3 		$39K Buy
+1
New +$43.2K ﹤0.01% 2063
2014
Q2 		– Hold
0
– – – 2060
2014
Q1 		– Hold
0
– – – 2010
2013
Q4 		– Hold
0
– – – 1982
2013
Q3 		– Hold
0
– – – 2005
2013
Q2 		– Hold
0
– – – 1941

Other funds holding YTEN

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FA
FCG Advisors Chatham, New Jersey $425M AUM 12.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return

William Blair & Company's YTEN Position: Q2 2015 in Review

William Blair & Company sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2015, closing a stake of 1 share — an estimated $26K sold.

William Blair & Company first reported a position in YTEN in Q3 2014 and held it in 3 quarters. The position peaked at $39K in Q3 2014. 11 funds tracked by Wall St. Rank hold YTEN as of Q2 2015.

  • William Blair & Company reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2015 after selling out during the quarter.
  • William Blair & Company sold 1 Yield10 Bioscience, Inc. Common Stock share in Q2 2015, an estimated $26K.
  • William Blair & Company first reported a position in Yield10 Bioscience, Inc. Common Stock in Q3 2014 and held it in 3 quarters.
  • William Blair & Company's Yield10 Bioscience, Inc. Common Stock position peaked at $39K in Q3 2014.
  • 11 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2015.

Based on William Blair & Company's 13F filing for Q2 2015, filed 3 Aug 2015.